CTLA4 and neoplasm: Tumor cells can evade the immune system in the TME by T-cell co-stimulation through tumor cell upregulation of immune-checkpoint co-signaling proteins such as cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) and programmed death-1 (PD-1) protein.